These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11281314)

  • 21. Subcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairment.
    Debette S; Bombois S; Bruandet A; Delbeuck X; Lepoittevin S; Delmaire C; Leys D; Pasquier F
    Stroke; 2007 Nov; 38(11):2924-30. PubMed ID: 17885256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular subcortical hyperintensities predict conversion to vascular and mixed dementia in MCI patients.
    Bombois S; Debette S; Bruandet A; Delbeuck X; Delmaire C; Leys D; Pasquier F
    Stroke; 2008 Jul; 39(7):2046-51. PubMed ID: 18436882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia.
    Bastos-Leite AJ; van der Flier WM; van Straaten EC; Staekenborg SS; Scheltens P; Barkhof F
    Stroke; 2007 Dec; 38(12):3182-5. PubMed ID: 17962598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of education on the neuropsychological assessment of the elderly: application and analysis of the results from the Mattis Dementia Rating Scale (MDRS)].
    Foss MP; Vale Fde A; Speciali JG
    Arq Neuropsiquiatr; 2005 Mar; 63(1):119-26. PubMed ID: 15830077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct cognitive profiles and rates of decline on the Mattis Dementia Rating Scale in autopsy-confirmed frontotemporal dementia and Alzheimer's disease.
    Rascovsky K; Salmon DP; Hansen LA; Galasko D
    J Int Neuropsychol Soc; 2008 May; 14(3):373-83. PubMed ID: 18419836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apathy: a major symptom in CADASIL.
    Reyes S; Viswanathan A; Godin O; Dufouil C; Benisty S; Hernandez K; Kurtz A; Jouvent E; O'Sullivan M; Czernecki V; Bousser MG; Dichgans M; Chabriat H
    Neurology; 2009 Mar; 72(10):905-10. PubMed ID: 19273824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive consequences of multiple lacunes and leukoaraiosis as vascular cognitive impairment in community-dwelling elderly individuals.
    Koga H; Takashima Y; Murakawa R; Uchino A; Yuzuriha T; Yao H
    J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):32-7. PubMed ID: 19110142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study.
    Steffens DC; Potter GG; McQuoid DR; MacFall JR; Payne ME; Burke JR; Plassman BL; Welsh-Bohmer KA
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):839-49. PubMed ID: 17623814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy.
    Staekenborg SS; Koedam EL; Henneman WJ; Stokman P; Barkhof F; Scheltens P; van der Flier WM
    Stroke; 2009 Apr; 40(4):1269-74. PubMed ID: 19228848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progressive morphometric and cognitive changes in vascular dementia.
    Gunstad J; Brickman AM; Paul RH; Browndyke J; Moser DJ; Ott BR; Gordon N; Haque O; Cohen RA
    Arch Clin Neuropsychol; 2005 Mar; 20(2):229-41. PubMed ID: 15708732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expanded normative data for the Mattis Dementia Rating Scale for use with urban, elderly medical patients.
    Bank AL; Yochim BP; MacNeill SE; Lichtenberg PA
    Clin Neuropsychol; 2000 May; 14(2):149-56. PubMed ID: 10916188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for dementia: comparison of three commonly used instruments.
    van Gorp WG; Marcotte TD; Sultzer D; Hinkin C; Mahler M; Cummings JL
    J Clin Exp Neuropsychol; 1999 Feb; 21(1):29-38. PubMed ID: 10420999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current concepts in vascular dementia].
    Benisty S
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Jun; 11(2):171-80. PubMed ID: 23803634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroimaging determinants of cognitive performances in stroke associated with small vessel disease.
    Mok V; Chang C; Wong A; Lam WW; Richards PS; Wong KT; Wong KS
    J Neuroimaging; 2005 Apr; 15(2):129-37. PubMed ID: 15746224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors for cognitive decline in patients with confluent white matter hyperintensities.
    Mok V; Xiong Y; Wong KK; Wong A; Schmidt R; Chu WW; Hu X; Lung Leung EY; Chen S; Chen Y; Tang WK; Chen X; Ho CL; Wong KS; Wong ST
    Alzheimers Dement; 2012 Oct; 8(5 Suppl):S96-S103. PubMed ID: 22651941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity of the dementia rating scale in vascular dementia: comparison between two sets of criteria to define cognitive impairment.
    Paul RH; Cohen RA; Moser DJ; Browndyke JN; Davis K; Gordon N; Sweet L; Lawrence JJ; Zawacki T
    Cerebrovasc Dis; 2003; 15(1-2):116-20. PubMed ID: 12499720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal cognitive decline in subcortical ischemic vascular disease--the LADIS Study.
    Jokinen H; Kalska H; Ylikoski R; Madureira S; Verdelho A; van der Flier WM; Scheltens P; Barkhof F; Visser MC; Fazekas F; Schmidt R; O'Brien J; Waldemar G; Wallin A; Chabriat H; Pantoni L; Inzitari D; Erkinjuntti T;
    Cerebrovasc Dis; 2009; 27(4):384-91. PubMed ID: 19276621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dementia rating scale performance: a comparison of vascular and Alzheimer's dementia.
    Lukatela KA; Cohen RA; Kessler HA; Jenkins MA; Moser DJ; Stone WF; Gordon NF; Kaplan RF
    J Clin Exp Neuropsychol; 2000 Aug; 22(4):445-54. PubMed ID: 10923054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia.
    Peters N; Opherk C; Danek A; Ballard C; Herzog J; Dichgans M
    Am J Psychiatry; 2005 Nov; 162(11):2078-85. PubMed ID: 16263847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.